Blog
Global Advocacy Success Series: JohnPeter, Tanzania
3 Nov 2021, 10:02 a.m. in Global Stories, Interviews by Katie Souris
JohnPeter exemplifies the resilient spirit and patient perseverance that any lifelong advocate must have. He says, ''Being a Global Advocate with T1International has taught me the resilience to fight for what I believe in.'' Read more
T1International Publishes Survey on Type 1 Diabetes, COVID, and Insulin Rationing
18 Oct 2021, 3:15 p.m. in #insulin4all USA, News & Statements by T1International
In September 2021, T1International’s latest out-of-pocket cost survey was published in the Journal of Diabetes Research and Clinical Practice. Conducted every two years, this study is the most comprehensive patient-led out-of-pocket cost survey for people living with type 1 diabetes. Read more
T1International Advocates Win: WHO Adds Long-Acting Insulin Analogues to EML
1 Oct 2021, 2:45 p.m. in News & Statements by T1International
T1International’s global community of people living with and affected by diabetes and their allies celebrates a monumental advocacy win as the World Health Organization announced the addition of long-acting insulin analogues to the Model List of Essential medicines (EML). Read more
T1International Hosts 3rd Annual #insulin4all Workshop
13 Sep 2021, 6:38 p.m. in #insulin4all USA, News & Statements by T1International
Join us for T1International’s annual #insulin4all Workshop: Advocate, Don’t Celebrate. This event is an opportunity for advocates from around the world to learn from each other, build community, and take action in the fight for #insulin4all. Read more
Global Advocacy Success Series: Cyrine, Lebanon
31 Aug 2021, 4:19 p.m. in Global Stories, Interviews by Katie Souris
T1International has provided tools and support to ensure Cyrine’s plans are detailed and realistic, and allowed her to connect with other advocates around the world who can offer support and guidance. Read more
Redirecting Guilt into Action
16 Jul 2021, 10:04 a.m. in #insulin4all USA, Global Stories by Elizabeth Roosevelt
It’s crucial that those of us who have access to insulin use our platform and privilege to fight for our community and for the people with diabetes who are solely focused on surviving. We must serve as the voice for the people with diabetes who can’t use their own because they’re bogged down working three jobs and choosing between putting food on the table for their family or insulin. Read more
T1International Comment on Application to Add Long-acting Insulin Analogues to WHO EML
17 Jun 2021, 9:03 a.m. in News & Statements by T1International
The WHO justifying inaction by saying it will not be adequate fails to address the issue of manufacturer monopolies and price-gouging. To see a world health leader taking this stance is extremely disheartening. Not to mention, civil society groups, including T1International, have coordinated actions to address the root causes of the issue. If the application is rejected for a third time, the diabetes community will continue to feel that the voices of people with diabetes do not matter and that the WHO is not listening to those who live this reality every day. Read more
Underrepresented Communities and Navigating the System
14 Jun 2021, 12:52 p.m. in #insulin4all USA, Global Stories by Alzahrra Almajid
Seven years after my diagnosis my brother was also diagnosed with type 1 diabetes which made the already bad financial burden worse. Although all people with diabetes struggle with how expensive diabetes can be, immigrants and people of color often do not have access to quality health insurance (or any access) so they are less likely to benefit from advanced diabetes technology. As I got older I began to understand how difficult it is to navigate a system that makes it harder for people in underrepresented communities to get adequate care. Read more
From Patient to Medical Student: My Journey with Diabetes Treatment
8 Jun 2021, 9:03 a.m. in Global Stories by Konstantina Taki
Having lived with type 1 diabetes for more than 12 years, I have experienced different aspects of the condition. First of all, as a patient, I approach diabetes from a personal view. I can also understand how the condition affects parents of children with diabetes. It's something new, demanding and difficult to handle. The last five years, as a medical student in Greece, I have seen diabetes from yet another more practical and scientific perspective. Read more
T1International Statement Endorsing H.R.3
2 Jun 2021, 9:59 a.m. in News & Statements
For years, T1International and our advocates have been calling on both state and federal legislators to take action to address exorbitant drug prices. American lives depend on real action. That’s why T1International USA endorses the Elijah E. Cummings Lower Drug Costs Now Act (H.R.3). Read more